Lineage Cell Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 05/15/2025 | 49.56 M | $22.38 M | 18.95% | 21.92% |
| BLACKROCK, INC. | 05/02/2025 | 11.45 M | $5.17 M | 13.46% | 5.07% |
| VANGUARD GROUP INC | 05/09/2025 | 8.92 M | $4.03 M | 3.31% | 3.95% |
| DEFENDER CAPITAL, LLC. | 04/28/2025 | 6.31 M | $3.16 M | 5.83% | 2.79% |
| RAFFLES ASSOCIATES LP | 05/15/2025 | 5.64 M | $2.55 M | 2.73% | 2.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 4.49 M | $2.03 M | 21.54% | 1.98% |
| COMERICA BANK | 05/14/2025 | 3.00 M | $1.35 M | 275.00% | 1.33% |
| STATE STREET CORP | 05/15/2025 | 2.65 M | $1.20 M | -0.91% | 1.17% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 2.51 M | $1.13 M | 0.00% | 1.11% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 2.29 M | $1.03 M | 0.36% | 1.01% |
| NORTHERN TRUST CORP | 05/13/2025 | 1.54 M | $695.28 K | 20.80% | 0.68% |
| MORGAN STANLEY | 05/15/2025 | 968.78 K | $437.50 K | 46.77% | 0.43% |
| GSA CAPITAL PARTNERS LLP | 05/08/2025 | 936.89 K | $423.00 K | 129.16% | 0.41% |
| JPMORGAN CHASE & CO | 05/12/2025 | 605.04 K | $273.24 K | -36.07% | 0.27% |
| ROYAL BANK OF CANADA | 05/15/2025 | 528.66 K | $237.00 K | 1,578.91% | 0.23% |
| 05/12/2025 | 515.45 K | $232.78 K | 100.00% | 0.23% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 503.19 K | $227.24 K | 20.90% | 0.22% |
| 05/12/2025 | 496.00 K | $223.99 K | 45.78% | 0.22% | |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 480.42 K | $216.96 K | 59.32% | 0.21% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 357.77 K | $161.57 K | 288.88% | 0.16% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 350.10 K | $158.11 K | -9.08% | 0.15% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 337.83 K | $152.56 K | 0.00% | 0.15% |
| UBS GROUP AG | 05/13/2025 | 263.92 K | $119.29 K | 19.48% | 0.12% |
| COOKSON PEIRCE & CO INC | 05/13/2025 | 250.00 K | $112.90 K | 100.00% | 0.11% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 236.11 K | $106.63 K | 272.92% | 0.10% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 223.36 K | $100.87 K | 156.85% | 0.10% |
| HRT FINANCIAL LP | 05/15/2025 | 208.92 K | $94.00 K | 100.00% | 0.09% |
| FMR LLC | 05/12/2025 | 204.11 K | $92.17 K | 1.59% | 0.09% |
| RHUMBLINE ADVISERS | 05/29/2025 | 201.45 K | $91.05 K | 9.87% | 0.09% |
| BARCLAYS PLC | 05/15/2025 | 195.05 K | $89.00 K | -16.67% | 0.09% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 174.70 K | $78.62 K | 0.00% | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 167.90 K | $75.82 K | -59.82% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 160.97 K | $72.60 K | 322.34% | 0.07% |
| CITIGROUP INC | 05/12/2025 | 128.10 K | $57.85 K | 5.13% | 0.06% |
| ORG PARTNERS LLC | 04/21/2025 | 115.40 K | $47.43 K | 100.00% | 0.05% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 113.45 K | $51.23 K | 19.55% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 104.06 K | $46.99 K | 22.85% | 0.05% |
| WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 05/15/2025 | 101.30 K | $45.75 K | 0.00% | 0.04% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 97.25 K | $43.83 K | 71.41% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 87.96 K | $39.72 K | 19.75% | 0.04% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 72.40 K | $33.00 K | -33.09% | 0.03% |
| JANE STREET GROUP, LLC | 05/19/2025 | 68.07 K | $30.74 K | -74.11% | 0.03% |
| MAI CAPITAL MANAGEMENT | 05/15/2025 | 64.39 K | $29.08 K | -90.21% | 0.03% |
| SG AMERICAS SECURITIES, LLC | 04/15/2025 | 63.16 K | $29.00 K | -8.43% | 0.03% |
| COMMONWEALTH EQUITY SERVICES, LLC | 05/09/2025 | 58.71 K | $27.00 K | 0.00% | 0.03% |
| INVESCO LTD. | 05/12/2025 | 58.04 K | $26.21 K | -6.06% | 0.03% |
| HIGHTOWER ADVISORS, LLC | 05/13/2025 | 57.71 K | $26.06 K | 0.00% | 0.03% |
| FORT SHERIDAN ADVISORS LLC | 05/01/2025 | 55.18 K | $24.92 K | 0.00% | 0.02% |
| INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 50.92 K | $23.00 K | 100.00% | 0.02% |
| CITADEL ADVISORS LLC | 05/15/2025 | 48.37 K | $21.85 K | -63.29% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lineage Cell Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 153 institutional investors and hedge funds held shares of Lineage Cell Therapeutics, Inc.. The most heavily invested institutionals were:
BROADWOOD CAPITAL INC: 49.56 M
BlackRock, Inc.: 11.45 M
VANGUARD GROUP INC: 8.92 M
Defender Capital, LLC.: 6.31 M
RAFFLES ASSOCIATES LP: 5.64 M
GEODE CAPITAL MANAGEMENT, LLC: 4.49 M
48.37% of Lineage Cell Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 118.82 M shares in the last 24 months. This purchase volume represents approximately $120.60 M in transactions.